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and large (> 6 cm), symptomatic or rapidly enlarging
aneurysms who present a dilemma to the operating sur-
geon. Under certain circumstances, watchful waiting may
be a reasonable course of action. However, because the
risk of aneurysm rupture increases to approximate the risk
of operative mortality, these patients would clearly benefit
from a less invasive surgical treatment.
Ligation treatment of aneurysms was described as early
as the time of Antyllus (second century AD) and described
by Cooper in 1817. In 1964, Blaisdell et al2 described an
alternative technique to conventional AAA repair in two
poor-risk patients. They described a two-stage procedure:
extra-anatomic axillobifemoral bypass graft was performed
first, followed by ligation of the proximal neck of the
aneurysm and bilateral iliac arteries 4 weeks later. Since this
original description, the term nonresective therapy for AAA
was coined, and several variations have been described with
widely varied results. Of most concern was the subsequent
rupture of several ligated aneurysms. This prompted devel-
opment of the total exclusion technique, which significantly
reduced the risk of future aneurysm rupture.3 Concomitant
with the development of interventional radiologic tech-
niques for arterial thrombosis, modifications to the original
procedure involved percutaneous thrombosis of the nonre-
sected aneurysm sac.4 This was accompanied by its own
attendant problems and concern regarding proximal clot
propagation in a nonligated proximal aneurysm neck.
As the overall population continues to age, with
increasing numbers of octogenarians, so increases the inci-
dence of aneurysmal disease. The mortality associated with
an unrepaired abdominal aortic aneurysm (AAA) greatly
exceeds the predicted mortality rate of aortic aneurysm
repair. The last 40 years have seen an evolution in the non-
emergency repair of infrarenal abdominal aneurysms.
Since Dubost et al1 performed the first aortic reconstruc-
tion in 1952, advances in perioperative monitoring and
management have made aneurysmectomy and reconstruc-
tion relatively safe with mortality rates of 2% to 5%. The
operative repair of choice remains aneurysmectomy with
graft reconstruction by either the transperitoneal or
retroperitoneal approach in the relatively healthy patients.
However, there is a subset of patients with comorbidities
(American Society of Anesthesiologists [ASA] class IV)
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Purpose: The mortality of an unrepaired abdominal aortic aneurysm (AAA) generally exceeds the mortality associated
with surgical repair. However, as our longevity increases, more frequently we see patients whose risk of surgical repair
approximates the risk of rupture. We present an extra-anatomic bypass graft with complete aneurysm exclusion by iliac
ligation and coil embolization of the aneurysm as an alternative for these high-risk patients.
Methods: An extra-anatomic bypass graft, followed by bilateral iliac artery ligation (retroperitoneal approach) and com-
plete coil embolization of the AAA, was performed in eight patients (mean age, 77 years) found to be at prohibitive
operative risk because of multiple comorbidities (American Society of Anesthesiologists class IV). Most patients (5 of
8) were symptomatic on presentation with a mean AAA diameter of 7 cm (range, 6.7-9.5 cm). We repair approximately
30 infrarenal aneurysms per year electively at our institution.
Results: All patients tolerated the surgical procedures. The average hospital stay was 8 days. All but two aneurysms
demonstrated complete thrombosis by 48 hours. After 48 months there was no incidence of graft thrombosis, periph-
eral ischemia, visceral ischemia or thrombus infection. There was one perioperative death from aspiration pneumonia.
Seventy-five percent (6 of 8) of patients have survived at least 1 year without surgical complications. No patient has
had a ruptured aneurysm.
Conclusion: Combining an extra-anatomic bypass graft and complete exclusion of the AAA by ligation of the common
iliac arteries and a coil embolization is an effective, less invasive treatment option for patients with AAA and prohibi-
tive operative risk. We emphasize the need for complete embolization documented by decreased aneurysm size. (J Vasc
Surg 2001;33:745-51.)
More recently, endoluminal stenting has evolved for
use in high-risk patients.5 This technique is very attractive
for certain patient populations with favorable aneurysm
morphology. However, technical problems with graft seat-
ing, endoleaks, and late graft thrombosis persist. We
describe a modification of the nonresective treatment of
AAA in which we ligate both common iliac arteries by
using a retroperitoneal approach, following the extra-
anatomic axillofemorofemoral bypass graft in combination
with coil/wire embolization by interventional radiology.
METHODS
Eight patients were selected for this nonresective
treatment of their AAA from February 1995 through
March 1999 on the basis of their underlying physiologic
condition and the size and presentation of their AAAs.
Because many patients are candidates for resection
through a retroperitoneal approach to minimize cardiac
stress, these eight patients were deemed at prohibitive
operative risk to undergo elective anuerysmectomy. Most
of our patients (6 of 8) were male with an average age of
77 years (range, 61-88 years). The aneurysm diameter
averaged 7 cm (range, 6-9.5 cm), and all were infrarenal
aneurysms, some with a patent inferior mesenteric artery
(IMA) and a variety of collateral feeding vessels. Most (5
of 8) of these patients presented with symptomatic
aneurysms (back pain, anorexia, lower extremity claudica-
tion and melena).
The decision to perform extra-anatomic bypass graft
and aortic exclusion, as opposed to direct aortic recon-
struction, was based on the presence and severity of multi-
ple comorbidities that significantly increased the predicted
operative risk to nearly approximate the risk of rupture.
Comorbidities considered significant included a history of
recent myocardial infarction (MI) (n = 3), congestive heart
failure (CHF) (n = 3), severe chronic obstructive pul-
monary disease (COPD) (n = 7), cirrhosis (0) and renal
insufficiency (n = 6). The average number of medical con-
ditions present in each patient was five. Table I provides a
summary of the clinical indications for each patient. In
agreement with the literature, most of our patients had car-
diac disease (arrhythmia/CHF/coronary artery disease
[CAD]), severe COPD (forced expiratory volume in 1 sec-
ond [FEV1] < 1 L), and chronic renal insufficiency (creati-
nine level > 1.2 mg/dL). All eight patients were evaluated
by their primary physicians and physiologic testing to be
ASA class IV patients with very poor operative risk.
All patients had computed tomography (CT) scans
and aortograms demonstrating the AAA. The preoperative
assessment included Doppler scanning studies of the sub-
clavian, carotid, and axillary arteries. Routine electrocar-
diogram, chest radiography, and baseline laboratory data
were gathered, as well as pulmonary function tests and
echocardiograms. Follow-up studies included a series of
abdominal CT scans and routine postoperative monitor-
ing, including Doppler flow studies, as needed.
Surgical repair involved a standard axillofemoro-
femoral bypass graft with patients under general anesthe-
sia, followed by immediate ligation of the common iliac
arteries. Specifically, a 10-mm externally supported poly-
tetrafluoroethylene (PTFE) graft was used for a right
axillofemoral bypass graft. The femorofemoral crossover
graft was done with an 8-mm externally supported PTFE
graft. Surgical ligation of the common iliac arteries was
accomplished with Tevdeck suture (Deknatel DSP
Worldwide, Fall River, Mass) through a standard retro-
peritoneal approach. A standard retroperitoneal incision
was made left lateral to the rectus sheath from the umbili-
cus to the tip of the 11th rib. The neck of the aneurysm
was dissected, the renal vessels were identified, and both
common iliac arteries were controlled and ligated in two
places with heavy Tevdek suture. In several cases the iliac
arteries were found to be heavily calcified. Double liga-
tures were placed as described above; in rare cases the cal-
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Table I. Clinical indications leading to an extra-anatomic approach to the AAA
Patient Age
no. (y) Clinical condition
1 63 8.7-cm AAA (symptomatic), severe COPD (FEV1 < 1 L), MI 2 y prior, CABG
2 71 8-cm AAA, end-stage renal disease (creatinine level = 5.8 mg/dL), CVA (multiple), ischemic colitis, atrial fibrilla-
tion, cardiomyopathy (ejection fraction < 30%), PVD (claudication)
3 83 9.5-cm AAA, aortic stenosis, BBB, CVA, CRI (creatinine level = 1.5 mg/dL)
4 61 6.7-cm AAA (symptomatic), lung cancer status post right upper and middle lobectomy, CVA, MI, CABG, PTCA, 
DVT, hemiplegia
5 88 8-cm AAA (symptomatic), CAD, CABG, PUD status post perforation, CRI (creatinine level = 1.2 mg /dL)
6 87 7-cm AAA (symptomatic), atrial fibrillation, angina, pacemaker, obesity, gout, CRI (creatinine level = 1.8 mg/dL),
HTN, pneumonia, COPD, CHF, gout
7 81 8-cm AAA (symptomatic), aortic stenosis, aortic insufficiency, COPD (FEV1 < 1 L, + tobacco), CRI (creatinine
level = 1.2 mg/dL), active alcoholic
8 81 7-cm AAA, COPD (home O2), MI, CABG, HTN, prior colon resection, cardiomyopathy (bedridden), TIA, atrial
fibrillation, cardiac arrest followed by PTCA of vein graft
CABG, Coronary artery bypass graft; BBB, bundle branch block; CVA, cerebral vascular accident; PVD, peripheral vascular disease; CRI, chronic renal insuf-
ficiency; PTCA, percutaneous transluminal coronary angioplasty; DVT, deep venous thrombosis; PUD, peptic ulcer disease; HTN, hypertension; TIA, tran-
sient ischemic attacks.
cified plaques required external crushing to securely per-
form the ligature. This added approximately 25 minutes
to the operative time, much less than the time required for
a full resection. The most recently managed patient in this
series (patient 8) had severe coexisting bilateral common
iliac occlusive disease, obviating the need for ligation of
the common iliac arteries and further decreasing the mor-
bidity of the procedure. All patients recovered in the
postanesthesia unit for 2 hours before transfer to the inter-
ventional radiology suites for the coil embolization.
Radiologic embolization has evolved with the devel-
opment of this technology since our series began.
Currently, a Tracker 325 catheter (Boston Scientific,
Watertown, Mass) is advanced coaxially through an intro-
ducer sheath until the tip is appropriately placed for the
placement of a series of Tracker coils or vortex wires to be
deployed for thrombosis of feeder arteries, including a
patent IMA. Fig 1 demonstrates the catheter placed for
embolization of a patent IMA and Fig 2 shows the final
shot of the thrombosed artery. After the thrombosis of
feeder vessels to the aneurysm, the catheter is advanced
into the AAA and a series of non–heparin-coated remov-
able core J-wires (0.035 in) with the removable core and
inner mandril removed are deployed. The number of wires
deployed depends on the size of the AAA. A final aor-
togram (Fig 3) is done to verify no residual filling of the
aneurysm. After operation, patients were followed up in a
monitored setting.
RESULTS
Extra-anatomic bypass graft, ligation of the common
iliac arteries bilaterally, and coil embolization of the
infrarenal aorta were performed in eight patients from
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February 1995 through March 1999. At our institution,
approximately 30 to 35 infrarenal AAAs are repaired each
year; more than 90% are repaired with the retroperitoneal
approach. The transperitoneal approach is reserved for
aneurysms involving the right renal vessels or in the pres-
ence of concomitant intra-abdominal disease. During our
follow-up period from 0 to 48 months, there was one peri-
operative death. Sixty-three percent (5 of 8) of our
patients remain alive and well and range between 3
months and 48 months from surgery (Table II). Our first
patient is alive and well after 48 months. Two patients had
a myocardial infarction and died 27 and 22 months after
surgery. One patient died of aspiration pneumonia on
postoperative day 8. In addition to her many medical
problems (including aortic stenosis, CHF, COPD, hyper-
Fig 1. Postoperative arteriogram demonstrating advancement of
catheter for embolization of IMA.
Fig 2. Final aortogram demonstrating coiled embolization of
IMA and other feeding vessels.
tension and renal insufficiency), she had a history of alco-
hol abuse, which may have contributed to her demise.
Although several patients have required hospitalization
for management of their medical conditions, none has
required intervention related to the original surgical proce-
dure. All axillofemoral grafts remain patent, and none has
required revision. Although accounts of rupture, visceral
ischemia, spinal ischemia, and infection of thrombosed aor-
tic sacs have been documented in the literature after non-
resective therapy,6 we have not encountered these
problems. In our series the neck of the aneurysm was not
ligated; however, no patient demonstrated worsened renal
function or evidence of proximal thrombus propagation.
Patients were admitted the morning of surgery, with
the exception of our first two patients, who were admitted
the day before surgery for preoperative placement of pul-
monary artery catheters and optimization of cardiac sta-
tus. Preoperative cardiac optimization was deemed
unnecessary after the postoperative course of the early
patients. The less invasive nature of the extra-anatomic
bypass graft leads to less dramatic fluid shifts, less opera-
tive blood loss, and less anesthesia time. At the conclusion
of the entire procedure, patients were always monitored
overnight in the intensive care unit (ICU) setting. The
average ICU stay was 3 days (range, 1-12 days). Several
patients remained intubated overnight; however, most
patients tolerated extubation in the operating room and
the interventional procedure under intravenous sedation.
Prolonged ICU stays were a result of poor pulmonary sta-
tus and subsequent respiratory failure.
The length of hospitalization was variable, but on the
average patients were hospitalized for 7 days (range, 4-18
days). One patient remained hospitalized for 13 days
because of her weakened premorbid condition. A second
patient with a protracted hospitalization had difficulty
with respiratory compromise. Patients regained bowel
function and began eating by the third day, on average.
Although there was no correlation between the number or
type of comorbid conditions and prolonged hospital stay,
underlying pulmonary status presented the most perioper-
ative difficulty. One patient had a postoperative urinary
tract infection, and one patient had some postoperative
confusion, which was resolved by postoperative day 3.
There were no postoperative wound infections. Postoper-
ative pain control was not problematic.
Abdominal CT scans were done routinely 2 days later
to verify thrombosis of the aneurysm. In two cases, throm-
bosis was not complete by 48 hours. One patient demon-
strated complete thrombosis by CT scan done on
postoperative day 8. The other patient required rethrom-
bosis at 1 month. In her case there were many collateral
vessels associated with the aneurysm before the original
procedure (Figs 4 and 5). The aneurysm was completely
thrombosed at the second sitting. For confirmation of
complete thrombosis, CT scans were done at 3 and 6
months after operation to demonstrate decreased AAA
size. Fig 4 shows a 9.5-cm AAA on a preoperative CT
scan. When compared with Fig 5, a CT scan at 3 months
after operation, a 20% decrease in the AAA size was
described by radiologic review. We have documented a
decrease in aneurysm size, no aneurysmal blood flow, or
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Fig 3. Final aortogram demonstrating coiled J-wires and total
exclusion of AAA.
Table II. Life table of survival
Time interval 
(mo after surgery) 0-12 13-24 25-36 37-48
No. died 1 1 1 0
No. entered 8 6 3 1
Probabilty of survival 0.875 0.833 0.667 1.0
Cumulative survival 0.875 0.729 0.486 0.486
both with Doppler scanning at intervals of 3 months after
operation to minimize the risk of rupture in each patient.
DISCUSSION
Aneurysm of the abdominal aorta is a highly lethal dis-
ease with the natural evolution leading to rupture and likely
death. The reported 5-year survival rate in untreated AAA
is 4% to 19%. In recent years repair of the aortic aneurysm
has become a fairly safe procedure, with an operative mor-
tality rate less than 5% in most centers. The standard
aneurysm resection and graft replacement can be performed
by either the transperitoneal or retroperitoneal approaches.
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Some authors think that the retroperitoneal approach con-
fers slightly less operative risk by minimizing third-space
losses and impaired respiratory mechanics.6 Nevertheless,
the risk of the operation increases with the presence of
severe comorbid conditions, including profound cardiac
dysfunction or ischemia, debilitating pulmonary disease and
renal insufficiency, in particular. Other patients who may
qualify for nonresective treatment of AAA are those
detected to have an intra-abdominal pathologic condition,
contamination from a perforation, or a cancerous lesion
that would compromise a direct aortic repair.
Nonresective therapy by extra-anatomic reconstruc-
Fig 4. Preoperative CT scan of 9.5-cm infrarenal AAA with numerous feeder vessels.
Fig 5. Postoperative CT scan of AAA shown in Fig 4.
tion with an axillofemorofemoral bypass graft, ligation of
the aortic outflow, and aneurysm embolization provides
an alternative therapy for patients with otherwise prohibi-
tive operative risk. Similarly, an iliac to iliac bypass graft
through the retroperitoneal approach could also be per-
formed, with the advantage of no groin dissection. There
are many physiologic advantages to this treatment in com-
parison to the traditional repair. During this operation the
dissection is largely confined to the subcutaneous tissues.
This provides for minimal tissue insult and the fluid shifts
associated with the traditional repair. The extra-anatomic
reconstruction provides for an aortic bypass graft, pre-
venting the physiologic changes associated with cross-
clamping the aorta for the traditional repair. The
percutaneous embolization precludes the need to ligate
the aneurysm neck, which involves a significant abdominal
or retroperitoneal incision with its attendant morbidity.
Ligation of the aortic outflow prevents the risk of distal
emboli or blue toe syndrome. One of our early patients
demonstrated significant hemodynamic instability during
the extra-anatomic bypass graft, and his procedure was
successfully performed in a staged manner during a period
of 3 days. Endovascular occlusion of the common iliac
arteries by covered stents may further decrease morbidity.
Extra-anatomic bypass graft with aortic exclusion is not
without potential disadvantages and complications.7,8 The
long-term patency rates of the more commonly performed
aortoiliac and aortofemoral grafts are far superior to those
of the axillofemorofemoral grafts. Five-year patency rates
of axillofemorofemoral grafts range from 30% to 80% com-
pared with 77% to 94% for aortofemoral grafts.9 Because
most grafts are placed for occlusive disease, it is difficult to
compare these two groups. LoGerfo et al10 demonstrated
flow rates up to 600 mL/min in axillobifemoral grafts,
twice the flow compared with axillofemoral grafts. The
higher flow seemed to be associated with a higher patency
rate as well. In our small series the patency of the grafts
continues to be 100%. We recommend the standard 10-
mm externally supported PTFE graft for the axillofemoral
limb and an 8-mm externally supported PTFE graft for the
femorofemoral crossover graft. With the increased use of
externally supported grafts we expect high patency rates to
be reported. In addition, technical factors regarding pre-
cise placement of the graft anastomosis to the proximal
axillary artery may also influence graft patency. We find
that such placement minimizes stress on the suture line.
The total exclusion of the aorta will also increase the
patency rate of our axillobifemoral bypass graft. In addi-
tion, a gentle curved inverse U-arch for femoral-femoral
crossover may promote better distal flow.
The literature is replete with case reports and studies
of the mortality and morbidity associated with nonresec-
tive treatment of AAA.7,8 The risk of subsequent
aneurysm rupture causes the most concern, which is the
precise complication of the disease we aim to treat. In a
large survey of 120 patients, Lynch et al8 documented a
34% rupture rate in patients treated with nonresective
therapy. The rate of aneurysm rupture was 20% in patients
in whom the infrarenal aorta had not been ligated. The
rupture rate was only 3% in patients in whom the
infrarenal aorta had been ligated. Pevec et al9 commented
on 33 incidents of post–nonresective treatment ruptures
and stated that 29 ruptures occurred in aneurysms that
had not undergone proximal ligation of the infrarenal
aorta. Complete aneurysmal thrombosis was not accom-
plished without ligation of the proximal and distal aorta.
Other authors have reported incidences of infected
aortic thrombus and the development of aortoenteric fis-
tula, as well as the potential for clot propagation to the
renal vessels.7 In cases of juxtarenal aneurysms, there is
concern for the possibility of renal artery thrombosis and
proximal propagation of thrombus, which would compro-
mise renal function. In our series we have not seen wors-
ening renal function or documented proximal thrombus
propagation. This is in agreement with the literature. After
28 months of follow-up, Reilly et al11 reported no docu-
mented proximal propagation of thrombus from infrarenal
aortic occlusion and worsening renal function in only four
of 52 patients as demonstrated by increased creatinine
level. Similarly, no patient has manifested symptoms asso-
ciated with infected thrombus, gastrointestinal ischemia or
other gastrointestinal complaints. Although the patency of
the internal and external iliac arteries was not directly mea-
sured, we think there is adequate collateral circulation.
Schwartz et al12 reported data following thrombosis of
the aneurysm sac by a variety of agents, concluding that
postoperative mortality and morbidity were exceedingly
high. Theoretically, inducing a complete thrombosis of the
aneurysm should unload the stress of the systemic arterial
pressure on the aortic aneurysm sac, thus preventing rup-
ture. In our series seven of eight patients underwent bilat-
eral ligation of the common iliac arteries through a
retroperitoneal incision followed by complete emboliza-
tion of the aneurysm. No patient has had rupture, and all
patients have demonstrated a decrease in the size of the
aneurysm (Table III). We think that complete thrombosis
of the aneurysm and documented decrease in AAA size are
mandatory for preventing the risk for future rupture.
Long-term survival rates for patients undergoing alter-
native procedures for the repair of AAAs are poor. Survival
rates of 59% at 1 year and 38% at 2 years have been
reported in a series of 26 patients.9 These authors
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Table III. Change in size of AAA
Patient AAA (cm) AAA (cm)
no. before surgery after surgery
1 8.7 8.0
2 8.0 7.0
3 9.5 8.5
4 6.7 5.3
5 8.0 4.8
6 7.8 7.3
7 8.0 Died postoperative day 8
8 7.0 6.6
reported that two of three patients with aneurysm rupture
did not have the neck of the aneurysm ligated. Complete
thrombosis of the aneurysms was not assured in this series.
In our series 63% of patients are alive at 18-month follow-
up. These patients will have poor long-term survival rates
based on their comorbid conditions alone, in comparison
with patients who tolerate the traditional repair. None of
our patients have suffered morbidity associated with this
less invasive procedure. Similar results for percutaneous
embolization were reported by Marnette et al.13 A com-
parison of results to endoluminal stenting would be more
meaningful. Unfortunately few studies are available, none
with long-term results.
Largely on the basis of the morbidities described for
nonresective therapy of AAAs, a case against its potential
usefulness has been argued.14 It is our opinion that dur-
ing the ensuing decade significant technologic advances
have been made that make revisiting nonresective ther-
apy worthwhile. Advances in medical management and
critical care have allowed us to extend the lives of many
people, presenting us with a much sicker patient popu-
lation. These same advances in critical care and anesthe-
sia have improved our ability to manage these patients
through certain surgical interventions. Postoperatively,
the enhancements in CT scanning allow us to accurately
determine not only whether the aneurysm is growing,
but also whether complete thrombosis has been accom-
plished and whether feeder vessels remain patent. In
addition, advances in interventional radiology now pro-
vide us with the means to intervene to complete the
thrombosis or embolize the feeder vessels, as needed.
Recently, endoluminal surgery has evolved to treat
AAAs.5 This technique is also amenable to treating high-
risk patients with potentially less morbidity. Similar rates of
survival are seen in patients with similar medical condi-
tions; however, long-term studies are not yet available.15
However, the technical constraints of this new technology
limit its usefulness. Our nonresective treatment can be
applied to any patient unsuitable for traditional repair,
whereas the endoluminal stenting is only useful in patients
with specific aneurysm morphology. In addition, endovas-
cular stenting is available only in larger academic hospital
settings at the present time. We emphasize that the proce-
dure of choice remains traditional aneurysmectomy with
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graft reconstruction in medically fit patients. On the basis
of our series, axillobifemoral bypass graft with bilateral
iliac ligation and infrarenal aneurysm embolization is an
effective and less invasive treatment for patients with
severe medical problems, symptomatic, anatomically com-
plicated, or rapidly enlarging AAAs.
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